Skip to main content
Have a personal or library account? Click to login
Association between Inflammatory Markers and Clinical and Metabolic Risk Factors for Cardiovascular Diseases Cover

Association between Inflammatory Markers and Clinical and Metabolic Risk Factors for Cardiovascular Diseases

Open Access
|Nov 2009

References

  1. Alber, H.F., Wanitschek, M.M., de Waha, S., Ladurner, A., Suessenbacher, A., Dorler, J., Dichtl, W., Frick, M., Ulmer, H., Pachinger, O., Weidinger, F. (2008). High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography.,(6), 372-380.
  2. Alberti, K.G.M., Zimmet, P., Shaw, J. (2005). The metabolic syndrome — a new world wide definition.,, 1059-1062.
  3. Berg, A.H., Scherer, P.E. (2005). Adipose tissue, inflammation, and cardiovascular disease.,, 939-949.
  4. Bilgili, S.C.A., Dogan, A., Karaca, B. (2008). Inverse relationship between adiponectin and plasminogen activator inhibitor-1 in metabolic syndrome patients.,(1), 63-68.
  5. Bonora, E., Targher, G., Alberiche, M., Bonadonna, R.C., Saggiani, F., Zenere, M.B., Monauni, T., Muggeo, M. (2000). Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity.,(1), 57-63.
  6. Caglayan, E.C., Blaschke, F., Takata, Y., Hsueh, W.A. (2005). Metabolic syndrome — interdependence of the cardiovascular and metabolic pathways.,, 135-142.
  7. Calabro, P., Limongelli, G., Pacileo, G., Di Salvo, G., Golino, P. (2008). The role of adiposity as a determinant of an inflammatory milieu.,(5), 450-460.
  8. Calabro, P., Yeh, E.T.H. (2008). Intra-abdominal adiposity, inflammation, and cardiovascular risk: New insight into global cardiometabolic risk.,, 32-38.
  9. El-Menyar, A.A. (2008). Cytokines and coronary artery disease: The state of the art.,(2), 139-151.
  10. Espinola-Klein, Ch., Rupprecht, H.J., Bickel, Ch., Lackner, K., Genth-Zotz, S., Post, F., Munzel, T., Blankenberg, S. (2008). Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome.,, 278-284.
  11. Florentin, M., Liberopoulus, E.N., Wierzbicki, A.S., Mikhailidis, D.P. (2008). Multiple actions of high-density lipoprotein.,, 370-378.
  12. Fuster, V., Sanz, J. (2008). Atherothrombosis: Past, present and future.,, spec. ed., 51-54.
  13. Gimeno, R.E., Klaman, L.D. (2005). Adipose tissue as an active endocrine organ: Recent advances.,, 122-128.
  14. Ikonomidis, I., Stamatelopoulos, K., Lekakis, J., Vamvakou, G.D., Kremastinos, D.Th. (2008). Inflammatory and non-invasive vascular markers: The multimarker approach for risk stratification in coronary artery disease.,, 3-11.
  15. Kahn, R., Buse, J., Ferrannini, E., Stern, M. (2005). The metabolic syndrome: Time for a critical cppraisal.,(9), 2289-2304.
  16. Khera, A., Mc Guire, D.K., Murphy, A.S., Stanek, H.S., Das, S.R., Vongpatanasin, W., Wians, F.H., Jr, Grundy, S.M., Lemos, J.A. (2005). Race and gender differences in C-reactive protein levels.,(3), 464-469.
  17. Lago, F., Diequez, C., Gomez-Reino, J., Gualillo, O. (2007). Adipokines as emerging mediators of immune response and inflammation.,(12), 716-725.
  18. Matsuzawa, Y. (2006). The metabolic syndrome and adipocytokines.,, 2917-2921.
  19. Miles, E.A., Rees, D., Banerjee, T., Cazzola, R., Lewis, S., Wood, R., Oates, R., Tallant, A., Cestaro, B., Yaqoob, P., Wahle, K.W., Calder, P.C. (2008). Age related increases in circulating inflammatory markers in men are independent of BMI, blood pressure and blood lipid concentrations.,, 298-305.
  20. Nilson, J. (2005). CRP-marker or marker of cardiovascular disease?,, 1527-1528.
  21. Pi-Sunyer, F.X. (2006). The relation of adipose tissue to cardiometabolic risk., 8 (Suppl. 4), S14-S23.
  22. Rosenson, R.S. (2005). New approaches in the intensive management of cardiovascular risk in the metabolic syndrome.,(5), 241-280.
  23. Ross, R. (1999). Atherosclerosis — An inflammatory disease.,, 115-126.
  24. Saltevo, J., Vanhala, M., Kautiainen, H., Kumpusalo, F., Laakso, M. (2008). Gender difference in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in metabolic syndrome: A population-based study.,(6), 747-750.
  25. Taeye, B.D., Smith, L.H., Vaughan, D.E. (2005). Plasminogen activator inhibitor-1 a common denominator in obesity, diabetes and cardiovascular disease.,, 149-154.
  26. Virani, S.S., Polsani, V.R., Nambi, V. (2008). Novel markers of inflammation in atherosclerosis.,(2), 164-170.
DOI: https://doi.org/10.2478/v10046-009-0041-6 | Journal eISSN: 2255-890X (formerly 1407-009X) | Journal ISSN: 1407-009X
Language: English
Page range: 204 - 209
Published on: Nov 6, 2009
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services

© 2009 Inga Stuķēna, Andrejs Kalvelis, Guntis Bahs, Uldis Teibe, Pēteris Tretjakovs, Aivars Lejnieks, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons License.